The Prevalence of Peritonitis among Pediatric Peritoneal Dialysis Patients at Large Saudi Center

Autor: Asrar Alqaedi, P J Parameaswari, Bayan Alnasser, Adnan A Mubaraki, Mohammed Bafaqeeh, Abdulaziz Alshathri, Abdulhadi Altalhi, Khalid Alsaran

Publikováno v: Saudi Journal of Kidney Diseases and Transplantation, Vol 32, Iss 4, Pp 973-978 (2021)

Peritonitis is a common and serious complication of peritoneal dialysis (PD) and it is a direct or major contributing cause of death in around 16% of PD patients. Severe or prolonged peritonitis leads to structural and functional alterations of the p

Externí odkaz: https://doaj.org/article/02c55fc0568447a7afc9d116b9dfa6e6

Free thyroxine, free triiodothyronine and thyroid-stimulating hormone before and after hemodialysis in Saudi patients with end-stage renal disease: Is there any difference?

Autor: Khalid Alsaran, Alaa Sabry, Hosamuddin Alshahhat, Enas Babgy, Fatemah Alzahrani

Publikováno v: Saudi Journal of Kidney Diseases and Transplantation, Vol 22, Iss 5, Pp 917-921 (2011)

Patients on regular hemodialysis (HD) suffer from a chronic illness that is believed not to involve the thyroid gland. However, they may have low levels of serum thyroxine (T4) and tri-iodothyronine (T3). It was found earlier that serum total T3 and

Externí odkaz: https://doaj.org/article/a83345db2cdb42c8a38f22c2dd07e3a6

Experience with second line drugs in frequently relapsing and steroid dependent childhood nephrotic syndrome in a large Saudi center

Autor: Khalid Mirza, Abdulhadi Al-Talhi, Esam Al-Kanani, Khalid Alsaran

Publikováno v: International Journal of Pediatrics and Adolescent Medicine, Vol 4, Iss 2, Pp 66-70 (2017)
International Journal of Pediatrics & Adolescent Medicine

Background and objectives: To assess the efficacy and safety of second line drugs used at our center in frequently relapsing and steroid dependant (FR/SD) childhood nephrotic syndrome. Patients and methods: This was a retrospective study over a perio

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e36eaa775a810f5bb91a2076d3a68a58

Treatment of chronic hepatitis C with peginterferon alfa-2b, plus ribavirin in end stage renal disease patients treated by hemodialysis: single Saudi center experience

Autor: Alaa Sabry, Khalid Alsaran, Azeb Molhem

Publikováno v: Renal Failure. 35:1305-1309

Hepatitis C virus (HCV) infection is a global health problem, common worldwide, leading to acute and chronic hepatitis and its consequences of hepatic cirrhosis and hepatocellular carcinoma. Antiviral therapy of HCV+ in dialysis patients with interfe

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::96565bd8fee7399de59cf2e6323a74bc
https://doi.org/10.3109/0886022x.2013.826136

Intravenous Alfacalcidol Once Versus Twice or Thrice Weekly in Hemodialysis Patients

Autor: Alaa Sabry, Abdulrazak H Alghareeb, Hassan Bawadekji, Khalid Alsaran

Publikováno v: Therapeutic Apheresis and Dialysis. 17:30-34

Secondary hyperparathyroidism remains a serious problem in hemodialysis patients. The use of vitamin D analogs still constitutes a basis for its treatment. This study was carried out to evaluate the efficacy of intravenous administration of alfacalci

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::88a399fb2e4ed4938a1c79f45c805f7e
https://doi.org/10.1111/j.1744-9987.2012.01131.x